Related references
Note: Only part of the references are listed.Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba et al.
BLOOD (2009)
An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors
N. Lei et al.
CANCER GENE THERAPY (2009)
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats
A. M. Sonabend et al.
CANCER GENE THERAPY (2009)
New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster
J. F. Spencer et al.
CANCER GENE THERAPY (2009)
INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies
B. Ying et al.
CANCER GENE THERAPY (2009)
An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector
D. L. Lichtenstein et al.
CANCER GENE THERAPY (2009)
Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
Konstantin Doronin et al.
HUMAN GENE THERAPY (2009)
In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones
Karen Sims et al.
JOURNAL OF GENE MEDICINE (2009)
Adenoviruses: update on structure and function
W. C. Russell
JOURNAL OF GENERAL VIROLOGY (2009)
Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity
Natalia Lapteva et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Targeting of Adenovirus Serotype 5 Pseudotyped with Short Fiber from Serotype 41 to c-erbB2-Positive Cells using Bispecific Single-Chain Diabody
Elena A. Kashentseva et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters
Debanjan Dhar et al.
JOURNAL OF VIROLOGY (2009)
Adenovirus E1B 55-Kilodalton Protein: Multiple Roles in Viral Infection and Cell Transformation
Andrew N. Blackford et al.
JOURNAL OF VIROLOGY (2009)
Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model
Debanjan Dhar et al.
MOLECULAR THERAPY (2009)
The tumour microenvironment: a novel target for cancer therapy
E. Hanna et al.
ORAL DISEASES (2009)
Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo
Michael A. van Geer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Use of Tissue-Specific MicroRNA to Control Pathology of Wild-Type Adenovirus without Attenuation of Its Ability to Kill Cancer Cells
Ryan Cawood et al.
PLOS PATHOGENS (2009)
Epidermal growth factor (EGF) receptor targeted delivery of PEGylated adenovirus
Ji Won Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
Alena Gros et al.
CANCER RESEARCH (2008)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer
Yuko Tsuruta et al.
CLINICAL CANCER RESEARCH (2008)
Development of PEGylated adenovirus vector with targeting ligand
Yusuke Eto et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Significant antitumor activity of oncolytic adenovirus expressing human interferon-β for hepatocellular carcinoma
Ling Feng He et al.
JOURNAL OF GENE MEDICINE (2008)
A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropism
Yue Zeng et al.
JOURNAL OF GENE MEDICINE (2008)
Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA
Erkko Ylosmaki et al.
JOURNAL OF VIROLOGY (2008)
Intrinsic structural disorder in adenovirus E1A: A viral molecular hub linking multiple diverse processes
Peter Pelka et al.
JOURNAL OF VIROLOGY (2008)
Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression
Sean E. Hofherr et al.
MOLECULAR THERAPY (2008)
Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model
Maria A. Thomas et al.
MOLECULAR THERAPY (2008)
Modification of adenovirus gene transfer vectors with synthetic polymers: A scientific review and technical guide
Florian Kreppel et al.
MOLECULAR THERAPY (2008)
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Roberto Cattaneo et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model
Karoly Toth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications
Zachary C. Hartman et al.
VIRUS RESEARCH (2008)
Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation
Y. Endo et al.
ONCOGENE (2008)
Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAIL
E. V. Shashkova et al.
CANCER GENE THERAPY (2008)
Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer
Natalya Belousova et al.
JOURNAL OF VIROLOGY (2008)
Improved gtioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses
Dennis Hoffmann et al.
JOURNAL OF GENE MEDICINE (2007)
Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters
Sergia Bortolanza et al.
HUMAN GENE THERAPY (2007)
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors
Tanja Hakkarainen et al.
HUMAN GENE THERAPY (2007)
Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles
Brett Hall et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Eradication of therapy-resistant human prostate tumors using a cancer terminator virus
Devanand Sarkar et al.
CANCER RESEARCH (2007)
Prostate cancer gene therapy clinical trials
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
Current advances and future challenges in adenoviral vector biology and targeting
Samuel K. Campos et al.
CURRENT GENE THERAPY (2007)
Targeting of adenovirus vectors carrying a tumor cell-specific peptide:: in vitro and in vivo studies
K. Rittner et al.
CANCER GENE THERAPY (2007)
Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice
Shanthi Ganesh et al.
CANCER RESEARCH (2007)
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
Justyna Leja et al.
CLINICAL CANCER RESEARCH (2007)
Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB/DOPE
Jason C. Steel et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Targeting interferon-α increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus
Elena V. Shashkova et al.
MOLECULAR THERAPY (2007)
Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth
Ji Young Yoo et al.
MOLECULAR THERAPY (2007)
Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver
T. Au et al.
CANCER GENE THERAPY (2007)
Cancer selective adenoviruses
Ramon Alemany
MOLECULAR ASPECTS OF MEDICINE (2007)
Clinical trials with oncolytic adenovirus in China
Wang Yu et al.
CURRENT CANCER DRUG TARGETS (2007)
Virology- and immunology-based gene therapy for cancer
Masatoshi Tagawa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
Joo-Hang Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses
Manel Cascallo et al.
HUMAN GENE THERAPY (2006)
Adenovirus infections in transplant recipients
MG Ison
CLINICAL INFECTIOUS DISEASES (2006)
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
Eric J. Small et al.
MOLECULAR THERAPY (2006)
The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p)
B. H. Shen et al.
GENE THERAPY (2006)
Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-γ gene yields efficient antitumor activity in immunodeficient and immunocompetent mice
Changqing Su et al.
MOLECULAR THERAPY (2006)
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
S Komarova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors
MA Thomas et al.
CANCER RESEARCH (2006)
Genetic identification of adenovirus type 5 genes that influence viral spread
T Subramanian et al.
JOURNAL OF VIROLOGY (2006)
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh et al.
CLINICAL CANCER RESEARCH (2006)
Identification of novel insertion sites in the Ad5 genome that utilize the Ad splicing machinery for therapeutic gene expression
F Jin et al.
MOLECULAR THERAPY (2005)
Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus
AJ Berk
ONCOGENE (2005)
Viruses - seeking and destroying the tumor program
CC O'Shea
ONCOGENE (2005)
Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression
M Kuppuswamy et al.
GENE THERAPY (2005)
Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice
D Sarkar et al.
CANCER RESEARCH (2005)
Inefficient killing of quiescent human epithelial cells by replicating adenoviruses: potential implications for their use as oncolytic agents
MT Vaillancourt et al.
CANCER GENE THERAPY (2005)
Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin
TR Reid et al.
CANCER GENE THERAPY (2005)
Functions of the adenovirus E4 proteins and their impact on viral vectors
MD Weitzman
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1
ZL Zhang et al.
MOLECULAR THERAPY (2005)
Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses
AH Picó et al.
MOLECULAR THERAPY (2005)
Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors
YH Wang et al.
CANCER RESEARCH (2005)
Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma
GC Li et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Adenovirus protein VI mediates membrane disruption following capsid disassembly
CM Wiethoff et al.
JOURNAL OF VIROLOGY (2005)
Cotton rat tumor model for the evaluation of oncolytic adenoviruses
K Toth et al.
HUMAN GENE THERAPY (2005)
Chimeric adenovirus vector encoding reovirus attachment protein σ1 targets cells expressing junctional adhesion molecule 1
GT Mercier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases
P Sova et al.
MOLECULAR THERAPY (2004)
A quantitative method for measuring gene expression magnitude and volume delivered by gene therapy vectors
KN Barton et al.
MOLECULAR THERAPY (2004)
Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor
EM Lee et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial
Wei Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
CC O'Shea et al.
CANCER CELL (2004)
The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma
S Morley et al.
CLINICAL CANCER RESEARCH (2004)
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector
MJ Chen et al.
GENE THERAPY (2004)
An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated Wnt signaling
K Toth et al.
CANCER RESEARCH (2004)
Oncolytic viral therapies
E Lin et al.
CANCER GENE THERAPY (2004)
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors
JJ Short et al.
VIROLOGY (2004)
Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2004)
Association of adenovirus with the microtubule organizing center
CJ Bailey et al.
JOURNAL OF VIROLOGY (2003)
Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer
M Yamamoto et al.
GASTROENTEROLOGY (2003)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Telomerase-dependent oncolytic adenovirus for cancer treatment
TG Huang et al.
GENE THERAPY (2003)
The impact of adenovirus infection on the immunocompromised host
T Kojaoghlanian et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
Dr. Gary J. Becker Young Investigator Award: Intraarterial adenovirus for metastatic gastrointestinal cancer: Activity, radiographic response, and survival
DY Sze et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2003)
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: Virus persists and spreads systemically at late time points
H Sauthoff et al.
HUMAN GENE THERAPY (2003)
Developing novel oncolytic adenoviruses through bioselection
W Yan et al.
JOURNAL OF VIROLOGY (2003)
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus
K Doronin et al.
VIROLOGY (2003)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
Intravascular adenoviral agents in cancer patients: Lessons from clinical trials
T Reid et al.
CANCER GENE THERAPY (2002)
Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma
LX Zhang et al.
MOLECULAR THERAPY (2002)
New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication
R Hernandez-Alcoceba et al.
HUMAN GENE THERAPY (2002)
Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer
HG van der Poel et al.
JOURNAL OF UROLOGY (2002)
Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells
MJ Savontaus et al.
GENE THERAPY (2002)
Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX
IP Dmitriev et al.
JOURNAL OF VIROLOGY (2002)
Tumor regression by targeted gene delivery to the neovasculature
JD Hood et al.
SCIENCE (2002)
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents
L Johnson et al.
CANCER CELL (2002)
Subcutaneous administration of a replication-competent adenovirus expressing HSV-tk to cotton rats: Dissemination, persistence, shedding, and pathogenicity
O Wildner et al.
HUMAN GENE THERAPY (2002)
Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma
N Habib et al.
CANCER GENE THERAPY (2002)
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy
M Ramachandra et al.
NATURE BIOTECHNOLOGY (2001)
Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial
T Reid et al.
GENE THERAPY (2001)
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5
MC Dechecchi et al.
JOURNAL OF VIROLOGY (2001)
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region
LK Hawkins et al.
GENE THERAPY (2001)
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
D Kirn et al.
NATURE MEDICINE (2001)
Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin
V Krasnykh et al.
JOURNAL OF VIROLOGY (2001)
Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas
E Galanis et al.
HUMAN GENE THERAPY (2001)
Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy
K Doronin et al.
JOURNAL OF VIROLOGY (2001)
Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway
M Brunori et al.
JOURNAL OF VIROLOGY (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
A novel, conditionally replicative adenovirus for the treatment of breast cancer that allows controlled replication of E1a-deleted adenoviral vectors
R Hernandez-Alcoceba et al.
HUMAN GENE THERAPY (2000)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein
K Doronin et al.
JOURNAL OF VIROLOGY (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen
T Kurihara et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
